What's in a name? FCB Health's powerhouse shop Area 23 extends its brand power

Award-winning ads, such as this one for a Bayer awareness campaign, are one reason Area 23 is extending its brand. (Area 23)

FCB Health’s latest agency is leveraging its Area 23 creative powerhouse brand name and talent with a new shop. Called Area 23 on Hudson, the new agency combines the creative acumen of its award-winning Area 23 with the medical communications expertise of Hudson Global, which had been a standalone FCB Health agency.

Area 23 creative director Tim Hawkey and managing director Renee Mellas will oversee the new venture, while Michael Lieberman from Area 23 and Jamie Cipriano from Hudson Global will handle day-to-day operations. Mellas attributed the move to client demand, as more and more seek agency partners to work with their brands from pre-launch through launch and beyond.

RELATED: After a Cannes coup, Area 23 creative chief spills his secrets—or most of them

3-Day Conference

6th Promotional Review Committee Compliance & Best Practices Conference

The leading U.S. event devoted to building the skills, speed and teamwork of your promotional review committee members will take place May 15–17, 2019 in Chicago. The conference is set to bring together more than 75 professionals to ensure your PRC is prepared to generate, collect and constructively act on expert comments for your entire drug and device portfolio.

“There are many clients blurring the line between promo med ed and AOR (agency of record) assignments. Area 23 On Hudson enables us to provide solutions that will infuse critical med ed needs with Area 23’s “What If” creativity,” said Mellas in an email interview, adding the new agency will also be able to more easily tap the FCB Health network of services and expertise.

Area 23 won nine creative awards at the Cannes Lions International Festival of Creativity this year, helping drive FCB Health's win as healthcare network of the year. The assist came just a year after Area 23 won its own healthcare agency of the year nod. Over the past seven years under Hawkey and Mellas, Area 23 has quadrupled in size and grown its creative reputation, regularly pulling awards from other major shows such as Clio Health, Effie Awards and the One Show.

RELATED: No pharma Grand Prix—again—at Cannes Lions Health, but record number of awards for drugmakers

When asked if this is the beginning of more Area 23 agency branding, Mellas didn’t answer directly but left the door open, saying Area 23 will “continue to embrace change and innovate to better deliver for our clients. That’s why we consider ourselves ‘never finished.’”

Suggested Articles

Sanofi is working on a succession plan for CEO Olivier Brandicourt, who'll hit mandatory retirement age in 2021.

Gilead CEO John Milligan racked up $26M in 2018 pay, on paper at least, while incoming chief Daniel O'Day is in line for a cool $30M this year.

Novo Nordisk has at least four more years to build up its newer diabetes drugs before they face Teva's versions of its $2.67B blockbuster Victoza.